Hosted on MSN12h
Global influenza vaccine market to hit $14b by 2032
Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...
TheMountainMail.com18h
Landfill sees influx in usage, necessitates expansion
The Chaffee County Landfill has seen an increase in usage. It did serve about 60 people a day before COVID, that number has ...
Hosted on MSN19h
NICE green lights two blood cancer therapies for NHS use
BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.
FierceBiotech22h
Roche rolls out new DNA 'sequencing-by-expansion' approach
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...
Researchers investigate rare side effect of blood cancer immunotherapy
Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...